tm logo
Trademark Search
ZACOL

View On IC.GC.CA

ZACOL
ABANDONED SECTION 36

on 21 Sep 2020

Last Applicant/ Owned by

COSMO TECHNOLOGIES LTD

Riverside II, Sir John Rogerson's Quay, Dublin 2

IE

Serial Number

1842561 filed on 14th Jun 2017

Correspondent Address

1100, boul. René-Lévesque Ouest25e ÉtageMontréal

QUÉBEC

CA

H3B5C9

ZACOL

Trademark usage description

medicines for intestinal disorders; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of diarrhea, antibiotic- Read More

Classification Information

Class [005]
Medicines for intestinal disorders; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of diarrhea, antibiotic-associated diarrhea, travellers' diarrhea, for colon and digestive system health and regulation, for improving energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for use in sanitary preparations for medical purposes, namely, nutraceutical preparations for colon and digestive system health and regulation, for maintenance and improvement of energy levels, and for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; pharmaceutical preparations for stimulating the growth of intestinal flora, restoring energy and metabolism of the colocyte and rescuing of the colonic mucosal trophism; pharmaceutical preparations for the treatment of colon disorders; pharmaceutical preparations for improving epithelial vitality and repair; pharmaceutical preparations for the prevention or treatment of cancer; pharmaceutical preparations for the prevention or treatment of colorectal cancer; pharmaceutical preparations for restoring the metabolic balance; pharmaceutical preparations for improving the trophic conditions of the mucosa; pharmaceutical preparations for regulating human gut homeostasis; pharmaceutical preparations for the treatment of gastro-intestinal disorders; pharmaceutical preparations for the treatment of inflammatory bowel disease, motility and functional disorders of the bowel such as IBS and colorectal tumours; pharmaceutical preparations for the maintenance of colon eubiosis; pharmaceutical preparations for decreasing intestinal inflammation; pharmaceutical preparations for promoting, supporting and maintaining a healthy colon; pharmaceutical preparations for the treatment of colitis, ulcerative colitis, Crohn's disease, radiation colitis, pouchitis, infectious colitis and shigellosis; pharmaceutical preparations for the treatment of polyposis of the colon; pharmaceutical preparations for the treatment of pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical and veterinary preparations in the form of tablets, capsules, sugar-coated pills, granules, powders or suppositories; Pharmaceutical preparations, namely, anti-flatulars; dietetic beverages and food consisting of butyric acid and inulin adapted for medical use; pharmaceutical preparations for the treatment of intestinal infections; pharmaceutical products, medical devices and diagnostics products related to gastro-intestinal diseases namely, diagnostic reagents for medical diagnostic use, gastrointestinal treatment preparations and pharmaceutical preparations for the treatment of gastro-intestinal diseases; nutraceuticals based on butyric acid and inulin that contribute to the restoration of intestinal barrier; lactic ferments for pharmaceutical use; biological products and supplements for medical use for treatment of the colon; dietary foods for medical use for treatment of the colon; food supplements consisting of butyric acid and inulin; dietary supplements for treatment of the colon; dietary supplements for general health and well-being; vitamin supplements; nutritional supplements for treatment of the colon; nutritional supplements for general health and well-being; dietary supplemental drinks for treatment of the colon; dietary supplemental drinks for general health and well-being; vitamin preparations in the form of food supplements for treatment of the colon; vitamin preparations in the form of food supplements for general health and well-being; nutraceutical products for use as dietary supplements for treatment of the colon; nutraceutical products for use as dietary supplements for general health and well-being; Nutraceutical preparations for therapeutic and medical purposes for treatment of the colon; Mineral supplements for human use

Classification kind code

11

Class [010]
Medical apparatus, namely pre-filled syringes for introducing pharmaceutical preparations, food supplements and nutraceuticals into the human body; Medical apparatus, namely pre-filled syringes for introducing pharmaceutical preparations, food supplements and nutraceuticals into the colon; Enema syringes; Enema apparatus for medical purposes; Rectal instruments, namely, medical instruments for use in rectal endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy procedures; Injection syringes; Syringes for medical purposes; Disposable hypodermic syringes for medical purposes

Classification kind code

11

Mark Details

Serial Number

1842561

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 10th Jul 2019		Registration Pending
Submitted for opposition 191
on 10th Jul 2019		Registration Fee Notice Sent
Submitted for opposition 42
on 17th Apr 2019		Advertised
Submitted for opposition 26
on 28th Mar 2019		Approved
Submitted for opposition 27
on 04th Feb 2019		Approval Notice Sent
Submitted for opposition 22
on 14th Jun 2018		Search Recorded
Submitted for opposition 20
on 14th Jun 2018		Examiner's First Report
Submitted for opposition 31
on 16th Jun 2017		Formalized
Submitted for opposition 1
on 15th Jun 2017		Created
Submitted for opposition 30
on 14th Jun 2017		Filed